Hims & Hers Engages Novo Nordisk on Potential Wegovy Treatment Offering

The telehealth company is in discussions with Danish pharmaceutical firm Novo Nordisk to provide Wegovy weight loss treatments to its patients.

Summary

No Summary provided as the original text is short

Terms & Concepts
  • Telehealth: The delivery of healthcare services remotely via telecommunications technology, enabling patient consultations without in-person visits.
  • Wegovy: A prescription weight loss drug containing semaglutide, developed by Novo Nordisk, approved for chronic weight management.
  • Novo Nordisk: A Danish multinational pharmaceutical company specializing in diabetes care and obesity treatments.